Mind Body Intervention for COVID-19 Long Haul Syndrome

Beth Israel Lahey Health

Status: Completed

Conditions: COVID-19 Long Haul Syndrome

Treatments: Behavioral: Mind Body Syndrome Therapy for Long Covid

Study type: Interventional

Funder types: Other

Identifiers

NCT04854772

2021P-000336

Details and patient eligibility

About

The present study is a feasibility study in which we will determine if a mind-body program that we have previously developed for chronic back pain can improve the multiple somatic complaints associated with the COVID Long Haul Syndrome.

Full description

This study is a pilot and feasibility study to determine if a mind-body program that we have previously developed for chronic back pain can improve the multiple somatic complaints associated with the COVID Long Haul Syndrome in patients without evidence of ongoing tissue injury. We will perform a 12-week intervention consisting of a series of classes which will focus on knowledge therapy, desensitization, emotional expression, and stress reduction.

Enrollment: 23 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patient ≥ 18 years old
• New symptoms attributed to the post-covid long-haul syndrome (extremity pain, dyspnea, headaches, chest pain, fatigue) occurring after an acute phase of COVID19
• Minimum of at least 12 weeks after the end of the acute phase of COVID-19 infection
• Persistence of symptoms for a least 1 month with no identified other organic etiology
• Score ≥ 3 or more on the SSS-8 score
• Symptoms present for a minimum of 4 days a week
• Willingness to consider mind-body intervention

Exclusion criteria

• Patients < 18 years of age
• Patients > 60 years of age
• Diagnosed (non-COVID-19) organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome (note that pain related to disc disease is not an exclusion unless there are neurological impairments).
• Patients with previous severe COVID-19 disease, defined as those who had been admitted to the ICU or have objective evidence of ongoing organ injury (e.g., persistent chest radiographic abnormalities or myocarditis)
• Identified lung or cardiac injury in subjects with chest pain or dyspnea (e.g., chest radiograph abnormalities, cardiac ultrasound showing myocarditis or depressed ejection fraction )
• Patients with a diagnosis of significant psychiatric comorbidities such as schizophrenia or dementia

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

23 participants in 1 patient group

Mind Body Syndrome Therapy for Long Covid

Experimental group

Description:

The participants will receive an initial one-on-one interview, followed by 1 to 2 hour biweekly group interactive, educational sessions for 12 weeks. This program also includes a day-long "retreat" at the end of the required course period. Participants will also be provided reading materials to study during the intervention period

Treatment:

Behavioral: Mind Body Syndrome Therapy for Long Covid